Double-blind, randomised clinical study comparing efficacy and safety of Methylprednisolone Aceponate 0.1% Cutaneous emulsion (Test) vs. Advantan Milk 0.1% Cutaneous emulsion (Reference) vs. Vehicle in patients with mild to moderate atopic dermatitis
Latest Information Update: 03 Feb 2020
At a glance
- Drugs Methylprednisolone aceponate (Primary)
- Indications Atopic dermatitis
- Focus Registrational; Therapeutic Use
- Sponsors Dermapharm
Most Recent Events
- 01 Feb 2020 Status changed from not stated to discontinued.
- 30 May 2019 New trial record